N/A
Completed N=871
Risk Markers in the Acute Coronary Syndromes
Source: ClinicalTrials.gov NCT00521976 ↗Enrolled (actual)
871
Serious AEs
0.0%
Results posted
Aug 2009
Primary outcomePrimary: Total Mortality. — 138 Participants.
Summary
The main aim of this trial is to assess the long-term prognostic value of different types of Factor XIIa in an unselected, single center series of 871 chest pain patients admitted to the emergency unit, employing blood samples collected at admission.
The second purpose of this study is to assess the incremental prognostic value of B-type natriuretic peptide (BNP) and high-sensitive C-reactive protein (hsCRP).
A third purpose of this study is to evaluate the prognostic impact of the Omega-3 Index which is a measure of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) relative to other fatty acids in the erythrocyte membrane.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Total Mortality. |
138 | — |
| SECONDARY Recurrent Troponin-T (TnT) Positive Events |
155 | — |
Eligibility Criteria
Inclusion Criteria
- adults > 18 years able to give informed consent
- a history of chest pain or other symptoms suggestive of an ACS leading to admission at the emergency unit
Exclusion Criteria
- < 18 years of age
- Unwillingness or incapacity to provide informed consent
- Prior admission resulting in inclusion in the present study
Data sourced from ClinicalTrials.gov (NCT00521976). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.